JPS5484555A - 13*144didehydrooprostaglandin*its manufacture and medical and veterinary composition containing said prostaglandin - Google Patents
13*144didehydrooprostaglandin*its manufacture and medical and veterinary composition containing said prostaglandinInfo
- Publication number
- JPS5484555A JPS5484555A JP13946478A JP13946478A JPS5484555A JP S5484555 A JPS5484555 A JP S5484555A JP 13946478 A JP13946478 A JP 13946478A JP 13946478 A JP13946478 A JP 13946478A JP S5484555 A JPS5484555 A JP S5484555A
- Authority
- JP
- Japan
- Prior art keywords
- prostaglandin
- medical
- manufacture
- composition containing
- veterinary composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000004519 manufacturing process Methods 0.000 title 1
- 150000003180 prostaglandins Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
- C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
- C07F9/65515—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT29654/77A IT1088966B (it) | 1977-11-15 | 1977-11-15 | 13,14-dideidro-prostaglandine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPS5484555A true JPS5484555A (en) | 1979-07-05 |
Family
ID=11228185
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP13946478A Pending JPS5484555A (en) | 1977-11-15 | 1978-11-14 | 13*144didehydrooprostaglandin*its manufacture and medical and veterinary composition containing said prostaglandin |
Country Status (8)
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006137472A1 (ja) * | 2005-06-24 | 2006-12-28 | Taisho Pharmaceutical Co., Ltd. | プロスタグランジン誘導体 |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH656877A5 (de) * | 1981-11-27 | 1986-07-31 | Erba Farmitalia | Optisch aktive oder racemische prostaglandinderivate. |
| GB2130575B (en) * | 1982-11-09 | 1985-12-11 | Erba Farmitalia | Amide derivatives of 13, 14-didehydro-cycloalkyl-prostaglandins |
| GB8329559D0 (en) * | 1983-11-04 | 1983-12-07 | Erba Farmitalia | Furyl derivatives of 16-substituted prostaglandins preparations |
| US5741810A (en) * | 1996-02-29 | 1998-04-21 | Allergan | Cyclopentane heptan(ene)oic acid, 2- heteroarylalkenyl derivatives as therapeutic agents |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1053781B (it) * | 1974-09-25 | 1981-10-10 | Erba C S P A Ora Farmitalia | Omega nor cicloalcil 13.14 deidro prostaglandine |
| IT1037126B (it) * | 1975-03-14 | 1979-11-10 | Erba Carlo Spa | 13.4 deidro ii desossi prosta glandine |
| IL49761A0 (en) * | 1975-06-27 | 1976-08-31 | Erba Carlo Spa | 16,16-dimethyl-prostaglandins and process for their preparation |
| FI71138C (fi) * | 1976-12-31 | 1986-11-24 | Erba Farmitalia | Foerfarande foer framstaellning av terapeutiskt aktiva bisykliska prostaglandiner |
-
1977
- 1977-11-15 IT IT29654/77A patent/IT1088966B/it active
-
1978
- 1978-10-27 ZA ZA00786075A patent/ZA786075B/xx unknown
- 1978-10-28 DE DE2847049A patent/DE2847049C2/de not_active Expired
- 1978-11-09 GB GB8117718A patent/GB2085872B/en not_active Expired
- 1978-11-09 GB GB7843910A patent/GB2009145B/en not_active Expired
- 1978-11-09 GB GB8117717A patent/GB2086373B/en not_active Expired
- 1978-11-13 BE BE191680A patent/BE871957A/xx not_active IP Right Cessation
- 1978-11-14 JP JP13946478A patent/JPS5484555A/ja active Pending
- 1978-11-15 FR FR7832270A patent/FR2408589A1/fr active Granted
-
1983
- 1983-05-10 US US06/493,294 patent/US4551476A/en not_active Expired - Fee Related
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006137472A1 (ja) * | 2005-06-24 | 2006-12-28 | Taisho Pharmaceutical Co., Ltd. | プロスタグランジン誘導体 |
| JP4985400B2 (ja) * | 2005-06-24 | 2012-07-25 | 大正製薬株式会社 | プロスタグランジン誘導体 |
Also Published As
| Publication number | Publication date |
|---|---|
| GB2085872B (en) | 1982-12-08 |
| DE2847049A1 (de) | 1979-05-17 |
| US4551476A (en) | 1985-11-05 |
| GB2086373A (en) | 1982-05-12 |
| GB2085872A (en) | 1982-05-06 |
| BE871957A (fr) | 1979-03-01 |
| FR2408589B1 (US07655688-20100202-C00086.png) | 1983-10-07 |
| GB2086373B (en) | 1982-11-24 |
| FR2408589A1 (fr) | 1979-06-08 |
| ZA786075B (en) | 1979-10-31 |
| GB2009145B (en) | 1982-08-11 |
| GB2009145A (en) | 1979-06-13 |
| DE2847049C2 (de) | 1987-04-16 |
| IT1088966B (it) | 1985-06-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPS5446786A (en) | Novel 3*4*55trihydroxypiperidine compound* its manufacture and use for medicine | |
| NZ188626A (en) | Acylanilides and pharmaceutical and veterinary compositions | |
| JPS5444644A (en) | Triphenylalkene derivative*its manufacture and medical composition containing said derivative for antiestrogenic hormone effect | |
| JPS5634628A (en) | Veterinary medicine composition and its manufacture | |
| JPS5441855A (en) | Propenylamine*its manufacture and medical composition containing it | |
| JPS5489031A (en) | Stabilized sterilizing agent composition and production thereof | |
| JPS5297921A (en) | Aralkylaniline derivative* preparation thereof and medical composition containing same | |
| JPS542341A (en) | Medical composition | |
| JPS54122275A (en) | Novel substituted diphenyllimidazolyllmethanes* their manufacture and their medical use | |
| JPS5466675A (en) | Omegaamercaptopropionamido*its manufacture and medical composition | |
| JPS5473765A (en) | Novel 66oxidatedd3*200dioxoopregnane derivatives*their manufacture and medical composition containing said compounds | |
| JPS54135779A (en) | 1*33dihydroo33*11*22*2*33dihydroo1*44benzoxinee22yl* 22hydroxyethyl*piperidinee44yl**2hhindolee22one novel derivative*its manufacture and use as drug and pharmateutical composition containing said de | |
| JPS55154973A (en) | 1*3*77trialkylxanthine* its manufacture and medical composition | |
| JPS5428829A (en) | Antiithrombosis medical composition | |
| JPS5488268A (en) | Novel imidazole derivatives*their manufacture and medical composition | |
| JPS5527172A (en) | Novel antibiotic*its manufacture and medical composition containing it | |
| JPS5517385A (en) | Benzimidazolinone derivative and medical composition containing it | |
| JPS5484555A (en) | 13*144didehydrooprostaglandin*its manufacture and medical and veterinary composition containing said prostaglandin | |
| JPS5490167A (en) | Novel tetracyclononane derivative*its manufacture and antivirulent medical composition containing it | |
| JPS5555155A (en) | 66methoxyy22acetylnaphthaleneoxime derivative*its manufacture and medical composition | |
| JPS5535086A (en) | Thazine derivative and medical composition | |
| JPS5481269A (en) | 11*naphthylethyl*imidazole derivatives*their manufacture and medical composition containing them | |
| JPS5321160A (en) | Novel 55thiazolealkylamine derivative* its preparation and medical composition | |
| JPS5448727A (en) | 11phenylethanolamine derivatives*manufacture and antiinflammatory medical composition containing thereof | |
| JPS5412373A (en) | 11aminoidoline * production thereof and medical composition containing same |